KLRA Kailera Therapeutics, Inc.
$13.94▼ -6.51%
Healthcare
Other
After hours
$13.94▲ +0.00%
Sep 11, 7:30 PM ET
Volume 815.4K
Avg Volume (10D) 762.5K
Key Metrics & Fundamentals
Market Cap
$1.81B
P/E Ratio
–
Div Yield
–%
52W Range
13.90 - 28.23
% vs 50 MA
-22.59%
% vs 200 MA
–%
RSI-14
33.0
MACD Histogram
-0.2300
Beta (1Y vs SPY)
1.05
Free Cash Flow
-$77.53M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$121.27M
COGS
–
Operating Exp
$121.37M
Operating Income
-$121.37M
EBIT
-$121.37M
Pretax Income
-$111.31M
Net Income
-$111.31M
EPS (Diluted)
-1.09
Price & Volume History
Loading chart…
Recent News
Kailera Therapeutics: The Record-Breaking Obesity IPO Big Pharma Cannot Ignore
24/7 Wall St. · Aug 18, 2026 2:10 PM
Kailera Therapeutics (KLRA) Reports Wider Losses And Names New CTO, Is The Low P B Justified?
Simply Wall St. · Aug 17, 2026 1:10 PM
2 GLP-1 Stocks That Could Double Your Money by 2031
Motley Fool · Aug 16, 2026 8:20 PM
Kailera Reports Second Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire · Aug 12, 2026 8:05 PM
Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer
GlobeNewswire · Aug 11, 2026 11:00 AM
2 Beaten-Down GLP-1 Stocks to Buy on the Dip
Motley Fool · Jul 15, 2026 5:20 AM
Kailera Therapeutics (KLRA) is One of the Best IPO Stocks with Huge Upside Potential
Insider Monkey · Jul 10, 2026 1:58 PM
Kailera weight loss pill trial results: Nausea sinks stock
Quartz · Jul 8, 2026 2:10 PM
Eli Lilly's Market Cap Balloons Again On This IPO's Setback
Investor's Business Daily · Jul 7, 2026 8:09 PM
Update: Kailera Says Oral Small Molecule KAI-7535 Achieves Up to 11% Weight Loss in Phase 3 Trial; Shares Fall
MT Newswires · Jul 7, 2026 6:49 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See KLRA's money flow as a full page
Social Sentiment
No Reddit posts found for KLRA.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.